Skip to main content

6 Result(s)

within C. Madroñal Remove this filter

and

  1. Article

    Open Access

    Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer

    The efficacy and safety of capecitabine and bevacizumab in elderly patients with metastatic colorectal cancer (mCRC) considered unsuitable for receiving first-line chemotherapy with an irinotecan or oxaliplati...

    J Feliu, M J Safont, A Salud, F Losa, C García-Girón, C Bosch… in British Journal of Cancer (2010)

    Download PDF (226 KB) View Article

  2. No Access

    Article

    Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer

    Purpose: To evaluate the feasibility, toxicity and efficacy of the combination of docetaxel and mitomycin C as second-line chemotherapy in patients with advanced non-small cell lung cance...

    J. Feliu, G. Martín, J. Castro, A. Sundlov… in Cancer Chemotherapy and Pharmacology (2006)

  3. No Access

    Article

    Biweekly regimen of cisplatin, gemcitabine and vinorelbine for advanced non-small-cell lung cancer

    Purpose: Improving chemotherapeutic efficacy in non-small cell lung cancer (NSCLC) will require the development of new strategies to better use currently available agents. To assess the e...

    Javier Castro de Carpeño, M. González Barón… in Cancer Chemotherapy and Pharmacology (2006)

  4. No Access

    Article

    Phase II study of a fixed dose-rate infusion of gemcitabine associated with docetaxel in advanced non-small-cell lung carcinoma

    To evaluate the efficacy and toxicity profile of the combination of docetaxel and prolonged gemcitabine infusion in front-line chemonaive patients with advanced non-small-cell lung cancer (NSCLC).

    J. De Castro, A. Lorenzo, S. Morales, J. Belón… in Cancer Chemotherapy and Pharmacology (2005)

  5. No Access

    Article

    Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer

    Epirubicin and docetaxel are two of the most active drugs against breast carcinoma. As the achievement of a pathological complete response (pCR) is important for survival of patients with locally advanced dise...

    E. Espinosa, S. Morales, P. Borrega, A. Casas… in Cancer Chemotherapy and Pharmacology (2004)

  6. No Access

    Article

    Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancer

    To evaluate the feasibility, toxicity and efficacy of the combination of low-dose cisplatin (CDDP) and gemcitabine (GEM) in elderly patients with advanced non-small-cell lung cancer (NSCLC).

    J. Feliu, G. Martín, C. Madroñal… in Cancer Chemotherapy and Pharmacology (2003)